Skip to content
Recall Observatory FDA recall evidence

Drug product

Ketorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL), packaged in 2 mL Single Dose Vials (NDC 0641-6043-01), 25 vials/shelf-pack (NDC 0641-6043-25), For IM Use Only, Rx only, Manufactured by: WEST-WARD Eatontown, NJ 07724 USA.

D-0658-2020

December 17, 2019

Class II

Product summary

Firm
Hikma Pharmaceuticals USA Inc.
Event
Event 84534
Status
Terminated
Classification
Class II
Quantity
25,817 shelf packs/25 vials per pack
Official record key
drug-enforcement:D-0658-2020

Official wording

Reason: Presence of Particulate Matter: particles identified as polydimethylsiloxane (PDMS)

Code information: 038368, Exp. Mar 2020; 058314, Exp. May 2020; 078305, 078307, Exp. July 2020; 118362 Exp. Nov 2020

Distribution pattern: Nationwide within the United States

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    Particulate Matter